Skip to main content
. 2020 Dec 28;12(8):3004–3016. doi: 10.1039/d0sc04670a

Fig. 2. Discovery of p53 TAD1 binding compounds 1047 and 1050. (A and D) Chemical structure of the compound 1047 and 1050. (B and E) SPR results of the binding affinity measurements between p53 TAD1 ligands and the p53 TAD1 peptide on an SA chip. (C and F) Competitive binding assay results by SPR.

Fig. 2